BLFS biolifesolutions.com: Return on Sales by Net Profit

BioLife - graphic logo of issuer BLFS

Despite the complexities of express delivery for biomaterials, BioLife Solutions, Inc. (BLFS) relies on its own high-tech facilities with strict cleanliness controls. Quarterly sales margins demonstrate current efficiency, with the indicator value standing at 46.40. This success is driven by management, which has transformed the company into an indispensable partner for the biotech sector through innovations in cell storage.

BioLife Solutions, Inc. (BLFS) - Company Sales Margin from 07/04/2022 to 10/18/2026

Comprehensive metric breakdowns and analytics for BioLife (BLFS)

- share price and consensus valuation forecast:
Analysis of all company metrics:BioLife Solutions, BLFS
Manufactured product of BioLife Corp

BioLife Solutions, Inc. (BLFS) efficiency in the gene therapy cryopreservation segment is driven by its ability to monetize stringent medical quality standards. The sales margin trajectory digitizes the share of net profit in every dollar of revenue, allowing investors to distinguish a temporary dip from a systemic decline in profitability and assess the business's financial cushion during shifts in biopharmaceutical cycles.

Who BioLife Solutions, Inc. competes with

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Return on Sales by Net Profit WVE (Wave Life Sciences Corp)|Company Sales Margin Maze Therapeutics Corp|Sionna Therapeutics Inc - Return on Sales by Net Profit|PRME (primemedicine.com) - Net Profit Margin|TSHA - Net Margin|QURE (uniQure) - Net Return on Sales|MeiraGTx Corp (MGTX) - Net Margin|Regenxbio - Net Profit Rate|Net Margin solidbio.com|Net Margin ocugen.com OCGN|Net Sales Margin PACB|Benitec - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX